74 related articles for article (PubMed ID: 9035989)
21. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
Duncan JC; Rogers R
J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
[TBL] [Abstract][Full Text] [Related]
22. Impact of atypical antipsychotics on outcomes of care in schizophrenia.
Joyce AT; Harrison DJ; Loebel AD; Ollendorf DA
Am J Manag Care; 2005 Sep; 11(8 Suppl):S254-61. PubMed ID: 16180964
[TBL] [Abstract][Full Text] [Related]
23. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
Surguladze S; Patel A; Kerwin RW; Knapp M; Travis MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352
[TBL] [Abstract][Full Text] [Related]
24. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
25. [Methodolocical issues of naturalistic observational studies on the economic evaluation of neuroleptic treatment for schizophrenic disease].
Kilian R; Angermeyer MC; Becker T
Gesundheitswesen; 2004 Mar; 66(3):180-5. PubMed ID: 15088222
[TBL] [Abstract][Full Text] [Related]
26. Costs of schizophrenia during 5 years.
Lindström E; Eberhard J; Neovius M; Levander S
Acta Psychiatr Scand Suppl; 2007; (435):33-40. PubMed ID: 17953524
[TBL] [Abstract][Full Text] [Related]
27. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of antipsychotic medication taking in people with schizophrenia.
McCann TV; Deans C; Clark E; Lu S
Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
[TBL] [Abstract][Full Text] [Related]
29. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
30. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
31. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
[TBL] [Abstract][Full Text] [Related]
32. Implementation of social services for the chronically mentally ill in a Polish mental health district: consequences for service use and costs.
Zaluska M; Suchecka D; Traczewska Z; Paszko J
J Ment Health Policy Econ; 2005 Mar; 8(1):37-44. PubMed ID: 15870484
[TBL] [Abstract][Full Text] [Related]
33. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
Phillips L; McCann E
J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
[TBL] [Abstract][Full Text] [Related]
34. Illness self-management for individuals in acute psychiatric care settings in Japan: cross-cultural adaptation of an American program.
Saito M; Edo K; Yamamoto Y; Niwa S; Liberman RP
Psychiatr Rehabil J; 2013 Dec; 36(4):272-7. PubMed ID: 24320836
[TBL] [Abstract][Full Text] [Related]
35. [The problem of drug compliance in schizophrenic patients].
Albus M
Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
[No Abstract] [Full Text] [Related]
36. An economic review of compliance with medication therapy in the treatment of schizophrenia.
Thieda P; Beard S; Richter A; Kane J
Psychiatr Serv; 2003 Apr; 54(4):508-16. PubMed ID: 12663838
[TBL] [Abstract][Full Text] [Related]
37. A group approach to psychopharmacology with schizophrenics.
Skolnick MR
Yale J Biol Med; 1985; 58(4):317-26. PubMed ID: 2864762
[TBL] [Abstract][Full Text] [Related]
38. Psychosis and medication: strategies for improving adherence.
Coffey M
Br J Nurs; 1999 Feb 25-Mar 10; 8(4):225-30. PubMed ID: 10347408
[TBL] [Abstract][Full Text] [Related]
39. Health beliefs and compliance with antipsychotic medication.
Budd RJ; Hughes IC; Smith JA
Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080
[TBL] [Abstract][Full Text] [Related]
40. [Compliance of schizophrenic patients with medication following discharge and their social background].
Hirai S
Sogo Kango; 1987; 22(2):85-104. PubMed ID: 3647857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
